Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT03776812 · COMPLETED

Trial details

NCT number: NCT03776812
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer Recurrent Fallopian Tube Carcinoma Recurrent Primary Peritoneal Carcinoma

Start date: 2019-04-05
Primary completion: 2021-03-16
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.